subject area of

• Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents  Academic Article
• Evolution of anti-HER2 therapies for cancer treatment  Academic Article
• Heterogeneity in the definition of dose-limiting toxicity in phase i cancer clinical trials of molecularly targeted agents: A review of the literature  Academic Article
• Speech-language pathology intervention in a youth justice setting: Benefits perceived by staff extend beyond communication  Academic Article